Neoplastic Syndrome Completed Phase 2 Trials for Leucovorin (DB00650)

Also known as: Neoplastic disease (disorder)

IndicationStatusPhase
DBCOND0028594 (Neoplastic Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00416767Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryTreatment